Malaysia

The company is set to pay 0.714 cents dividend per ordinary share.

IJN's has carried out 36,381 screenings for its outreach programme, which targets rural areas in Peninsular Malaysia.

These will bring Malaysia closer in line with the ASEAN medical device directive.

The project “Better Facilities, Better Care” encapsulates the centre’s commitment to high-quality healthcare services.

The government will be urged to expand access to healthcare services.

The deal would give IHH a larger share in the medical tourism market in Klang Valley.

Singapore and Malaysia’s EBITDA earnings grew 28% and 29%, respectively.

Domestic direct investments more than doubled in 2018 to $372m.

This comes as the government aims to be aligned with the WHO’s recommended healthcare spending of 7% of GDP.

Its 2018 medical device investments of $160.2m paled in compariston to 2017’s $500m.

It will allocate $8.4m of its healthcare budget to boost Malaysia’s image as a health tourism destination.

It seeks to establish more government partnerships.

Only 20% of hospitals currently have this capability.

It allocated $4.77m in 2019.

With a depth of expertise consisting of over 240 super-specialised experts, University Malaya Specialist Centre takes its congregation of wide-ranged specialties to the forefront of healthcare in Malaysia.

InterSystems IRIS for Health is the world's first and only data platform engineered specifically for healthcare.